PIMJS
UTHR icon

PKO Investment Management Joint-Stock’s United Therapeutics UTHR Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Buy
500
+200
+67% +$113K 0.02% 218
2026
Q1 		$178K Sell
300
-200
-40% -$99.6K 0.02% 214
2025
Q4 		$244K Buy
+500
New +$233K 0.02% 210

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

PKO Investment Management Joint-Stock's UTHR Position: Q2 2026 in Review

PKO Investment Management Joint-Stock increased its United Therapeutics (UTHR) stake by 67% in Q2 2026, buying an estimated $113K and bringing the position to 500 shares worth $271K. The position accounts for 0.02% of the portfolio, ranked #218.

PKO Investment Management Joint-Stock first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. 281 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • PKO Investment Management Joint-Stock held 500 shares of United Therapeutics worth $271K as of Q2 2026.
  • PKO Investment Management Joint-Stock bought 200 United Therapeutics shares in Q2 2026, an estimated $113K.
  • United Therapeutics made up 0.02% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #218 holding.
  • PKO Investment Management Joint-Stock first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 281 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.